RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/0A3F722916E5555EF49CA8F81FE8481C9449A250957A818E09EFE2C0A06A34DDD4A74CDACA3FEBD9A4F956401A23155Fhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0A3F722916E5555EF49CA8F81FE8481C9449A250957A818E09EFE2C0A06A34DDD4A74CDACA3FEBD9A4F956401A23155Fhttp://www.w3.org/2000/01/rdf-schema#comment"Data suggest that integrating clinical information with sweat chloride levels cystic fibrosis transmembrane conductance regulator (CFTR) genotype and pancreatic sufficiency provides a context for continued longitudinal monitoring of patients for personalized and effective treatment of cystic fibrosis (CF)."xsd:string
http://purl.uniprot.org/uniprot/#_9B16E8148D9EB02D265F4BB0AF0C2E83149D58459B998DB644D5F8E17C11412865683AF67598DAFCF1B069370A02AF85http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/0A3F722916E5555EF49CA8F81FE8481C9449A250957A818E09EFE2C0A06A34DDD4A74CDACA3FEBD9A4F956401A23155F
http://purl.uniprot.org/uniprot/Q6KEA0http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/0A3F722916E5555EF49CA8F81FE8481C9449A250957A818E09EFE2C0A06A34DDD4A74CDACA3FEBD9A4F956401A23155F
http://purl.uniprot.org/uniprot/#_Q6KEA0-mappedCitation-26671754http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/0A3F722916E5555EF49CA8F81FE8481C9449A250957A818E09EFE2C0A06A34DDD4A74CDACA3FEBD9A4F956401A23155F